New Shingrix data demonstrate 100% vaccine efficacy in the prevention of shingles in adults aged 50 and over in China
Provider: View Press Release Type: Link Title: New Shingrix data demonstrate 100% vaccine efficacy in the prevention of shingles in adults aged 50 and over in China | GSK Description: No cases of shingles (herpes zoster) reported among the participants who received Shingrix in the randomised clinical trial
New research published in Science highlights potential of a naturally occurring bacterium to help eradicate malaria
Provider: View Press Release Type: Link Title: New research published in Science highlights potential of a naturally occurring bacterium to help eradicate malaria | GSK Description: GSK scientists have discovered a strain of Delftia tsuruhatensis bacterium, that inhibits P. falciparum malaria parasites in mosquitoes.
Jemperli (dostarlimab) plus chemotherapy approved in the US as the first new frontline treatment option in decades for dMMR/MSI-H primary advanced or recurrent endometrial cancer
Jemperli (dostarlimab) plus chemotherapy approved in the US as the first new frontline treatment option in decades for dMMR/MSI-H primary advanced or recurrent endometrial cancer
Provider: View Press Release Type: Link Title: Jemperli (dostarlimab) plus chemotherapy approved in the US as the first new frontline treatment option in decades for dMMR/MSI-H primary advanced or recurrent endometrial cancer | GSK Description: Jemperli is the only immuno-oncology treatment approved in a frontline setting for this patient population in combination with chemotherapy
ViiV Healthcare’s cabotegravir for HIV prevention receives positive CHMP opinion from European Medicines Agency
Provider: View Press Release Type: Link Title: ViiV Healthcare’s cabotegravir for HIV prevention receives positive CHMP opinion from European Medicines Agency | GSK Description: Cabotegravir is the first and only long-acting injectable option for pre-exposure prophylaxis to reduce the risk of sexually acquired HIV-1
New analysis shows lost ground on adult immunisation during the pandemic with 100 million doses potentially missed
Provider: View Press Release Type: Link Title: New analysis shows lost ground on adult immunisation during the pandemic with 100 million doses potentially missed | GSK Description: Despite successes in Covid-19 vaccination programmes, global uptake of some other adult vaccines fell during the same timeframe
